SCHEMBL19314647

SCHEMBL19314647

C/C=C(\C)c1ccc(-c2ccc(/C(C)=C/N=C(\C)[C@@H](C)CCCC)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ BDKRB2 P30411 1/20 0.33
▸ RARB P10826 2/20 0.31
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25006433 0.83 NQO2 (0.38) —
SCHEMBL25008403 0.69 F2R (0.33) —
SCHEMBL25008044 0.68 CA1 (0.34) —
SCHEMBL25006755 0.65 KCNH2 (0.35) —
SCHEMBL25008019 0.63 PNMT (0.37) NPC1RAB9A
SCHEMBL27892537 0.62 THRA (0.56) RARB
SCHEMBL11414654 0.61 ESR1 (0.46) RAB9A
SCHEMBL9242259 0.59 CA1 (0.41) —
SCHEMBL9242261 0.59 CA1 (0.41) —
SCHEMBL25007269 0.58 CA1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968302-B9 COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS ABBVIE INC (US) 2019-02-13 — — EP disclosed
EP-2968302-B1 COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS ABBVIE INC (US) 2017-09-06 — — EP disclosed
Send feedback